Six Links For Your Consideration June 25, 2025 1. A Virtual Conversation with Heather Cox Richardson and DNC Chair Ken Martin — next Monday at 3pm Eastern, 12pm Pacific. If you’re not... Saving Advice · Jun 25, 2025
3 Standout Penny Stocks to Watch This April Investing in penny stocks carries substantial risk, but also offers the potential for significant returns. These penny stocks, all with bullish analyst ratings, have considerable upside potential, according to Wall Street. Barchart · Apr 16, 2024
Why Veru Stock Is Soaring Veru Inc (NASDAQ: VERU) shares are trading higher Wednesday after the company announced the publication of the results from a Phase 3 COVID-19 study evaluating the efficacy and safety of oral sabizabulin for the treatment of hospitalized moderate-severe COVID-19 patients at high risk for acute res Benzinga · Jul 6, 2022
Veru's Return On Capital Employed Insights Veru (NASDAQ:VERU) brought in sales totaling $13.03 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 122.22%, resulting in a loss of $14.18 million. Benzinga · Jun 16, 2022
Veru Seeks FDA Emergency Use Nod For Its COVID-19 Treatment Veru Inc (NASDAQ:VERU) has submitted an emergency use authorization (EUA) for sabizabulin application to FDA for COVID-19 treatment. The application covers moderate to severe hospitalized COVID-19 patients at high risk for developing Acute Respiratory Distress Syndrome (ARDS). The EUA submission is based on the positive results from the Phase 3 COVID-19 clinical trial… Benzinga · Jun 7, 2022
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study Here's a roundup of top developments in the biotech space over the last 24 hours: Benzinga · Jun 7, 2022
Analyst Ratings for Veru Over the past 3 months, 4 analysts have published their opinion on Veru (NASDAQ:VERU) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Benzinga · May 18, 2022
So What's Up With Veru Shares Rising Today? Shares of companies in the broader consumer staples sector, including Veru Inc (NASDAQ: VERU), are trading higher as stocks rebound from recent weakness. Stocks have experienced volatility this year amid Fed policy tightening measures. Benzinga · May 17, 2022
Veru Whale Trades For May 16 A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 14 strange trades. Benzinga · May 16, 2022
How Is The Market Feeling About Veru? Veru's (NASDAQ:VERU) short percent of float has risen 278.79% since its last report. The company recently reported that it has 10.94 million shares sold short, which is 16.97% of all regular shares that are available for trading. Benzinga · May 16, 2022
Mid-Afternoon Market Update: Nasdaq Jumps 400 Points; Duolingo Shares Spike Higher U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite adding 400 points on Friday. Benzinga · May 13, 2022
56 Stocks Moving In Friday's Mid-Day Session Gainers Veru Inc. (NASDAQ: VERU) shares jumped 62.5% to $14.67 after the company reported quarterly results on Thursday. Jefferies maintained Veru with a Buy and raised the price target from $33 to $55. Benzinga · May 13, 2022
Recap: Veru Q2 Earnings Veru (NASDAQ:VERU) reported its Q2 earnings results on Thursday, May 12, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Benzinga · May 12, 2022
52 Stocks Moving In Wednesday's Mid-Day Session Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million. Benzinga · May 11, 2022
Benzinga · May 11, 2022 The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine Here's a roundup of top developments in the biotech space over the last 24 hours:
Benzinga · May 11, 2022 Why Veru Shares Are Soaring Today Premarket In a Pre-EUA meeting, FDA said Veru Inc (NASDAQ:VERU) should submit a request for FDA emergency use authorization for sabizabulin in hospitalized COVID-19 patients. The FDA agreed that the Phase 3 COVID-19 study stopped by the Independent Data Monitoring Committee for overwhelming efficacy is sufficient to support the efficacy portion of a request for…
Benzinga · May 2, 2022 Veru Whale Trades Spotted A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 21 strange trades.
Benzinga · May 2, 2022 5 Short Squeeze Candidates To Watch This Week: Aterian, Harbor Custom Development Remain At The Top, Veru Joins Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move.
StockNews.com · Apr 21, 2022 Up 200% in Just the Past Month, is Veru Stock Still a Buy? Veru Inc. (VERU) stock has exhibited solid momentum over the past few weeks owing to the company’s recent clinical study of oral medicine sabizabulin, which reduces fatalities by more than 50% in severe COVID-19 patients. However, given Veru’s declining revenue and poor profitability, can the stock sustain its price rally?…
Benzinga · Apr 20, 2022 Looking At Veru's Recent Whale Trades A whale with a lot of money to spend has taken a noticeably bearish stance on Veru. Looking at options history for Veru (NASDAQ:VERU) we detected 10 strange trades.
Benzinga · Apr 12, 2022 Why Veru May Be Set To Double, Triple In Price And How To Play This Consolidation Pattern Veru Inc (NASDAQ: VERU) shot up 235% at one point on Monday before closing the trading session up more than 180% off Friday’s closing price. On Tuesday, the stock was consolidating the move higher by setting up an inside bar pattern on the daily chart.
Benzinga · Apr 12, 2022 Benzinga's Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl's Corporation, BioCardia, And More Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the
Benzinga · Apr 11, 2022 Why Veru Shares Are Rising After Hours Veru Inc (NASDAQ: VERU) shares are trading higher in Monday's after-hours session on continued momentum from the regular session.
Benzinga · Apr 11, 2022 Veru's Stock Nearly Triples As COVID-19 Drugs Cuts Reduces Deaths By 55% In Hospitalized Patients Veru Inc (NASDAQ: VERU) has
Benzinga · Apr 11, 2022 Why Veru Stock Is Surging Today Veru Inc (NASDAQ: VERU) shares are trading significantly higher Monday after the company reported its novel COVID-19 drug candidate reduced deaths by 55% in hospitalized patients in an interim analysis of the Phase 3 study.